Publications
Here you can browse the complete list of publications for studies listed on CDAS.
| Title | PubMed | Authors | Journal | Year | Studies |
|---|---|---|---|---|---|
| Association of dietary tomato intake with bladder cancer risk in a prospective cohort of 101,683 individuals with 12.5 years of follow-up. | 34244460 | Xu X, Xie B, Li S, Wang S, Xia D, Meng H | Aging (Albany NY) | 2021 | PLCO |
| Lung Nodule Malignancy Prediction in Sequential CT Scans: Summary of ISBI 2018 Challenge. | 34264825 | Balagurunathan Y, Beers A, Mcnitt-Gray M, Hadjiiski L, Napel S, Goldgof D, Perez G, Arbelaez P, Mehrtash A, Kapur T, Yang E, Moon JW, Perez GB, Delgado-Gonzalo R, Farhangi MM, Amini AA, Ni R, Feng X, Bagari A, Vaidhya K, Veasey B, Safta W, Frigui H,… | IEEE Trans Med Imaging | 2021 | NLST |
| Instrumental variable estimation of early treatment effect in randomized screening trials. | 34254205 | Saha S, Liu Z, Saarela O | Lifetime Data Anal | 2021 | NLST |
| Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions. | 34255745 | Gutkind JS, Molinolo AA, Wu X, Wang Z, Nachmanson D, Harismendy O, Alexandrov LB, Wuertz BR, Ondrey FG, Laronde D, Rock LD, Rosin M, Coffey C, Butler VD, Bengtson L, Hsu CH, Bauman JE, Hewitt SM, Cohen EE, Chow HS, Lippman SM, Szabo E | JCI Insight | 2021 | EPPT |
| Dietary phytoestrogen intake and lung cancer risk: an analysis of the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial. | 34370838 | Wang Q, Ru M, Zhang Y, Kurbanova T, Boffetta P | Carcinogenesis | 2021 | PLCO |
| Associations of Dietary Fat Intake With Mortality From All Causes, Cardiovascular Disease, and Cancer: A Prospective Study. | 34434952 | Yao X, Xu X, Wang S, Xia D | Front Nutr | 2021 | PLCO |
| Association of Inclusion of More Black Individuals in Lung Cancer Screening With Reduced Mortality. | 34427681 | Prosper AE, Inoue K, Brown K, Bui AAT, Aberle D, Hsu W | JAMA Netw Open | 2021 | NLST |
| Evaluation of Alternative Diagnostic Follow-up Intervals for Lung Reporting and Data System Criteria on the Effectiveness of Lung Cancer Screening. | 34419477 | Bastani M, Toumazis I, Hedou' J, Leung A, Plevritis SK | J Am Coll Radiol | 2021 | NLST |
| Association of the Age at Menarche with Site-Specific Cancer Risks in Pooled Data from Nine Cohorts. | 33820799 | Fuhrman BJ, Moore SC, Byrne C, Makhoul I, Kitahara CM, Berrington de González A, Linet MS, Weiderpass E, Adami HO, Freedman ND, Liao LM, Matthews CE, Stolzenberg-Solomon RZ, Gaudet MM, Patel AV, Lee IM, Buring JE, Wolk A, Larsson SC, Prizment AE, Ro… | Cancer Res | 2021 | PLCO |
| Genetic variants of DOCK2, EPHB1 and VAV2 in the natural killer cell-related pathway are associated with non-small cell lung cancer survival. | 34094683 | Du H, Liu L, Liu H, Luo S, Patz EF, Glass C, Su L, Du M, Christiani DC, Wei Q | Am J Cancer Res | 2021 | PLCO |
| Development and Validation of an Interpretable Artificial Intelligence Model to Predict 10-Year Prostate Cancer Mortality. | 34205398 | Bibault JE, Hancock S, Buyyounouski MK, Bagshaw H, Leppert JT, Liao JC, Xing L | Cancers (Basel) | 2021 | PLCO |
| An investigation of cross-sectional associations of a priori-selected dietary components with circulating bile acids. | 34477829 | Byrd DA, Sinha R, Weinstein SJ, Albanes D, Freedman ND, Sampson J, Loftfield E | Am J Clin Nutr | 2021 | PLCO |
| Association of genetic variants in autophagy-lysosome pathway genes with susceptibility and survival to prostate cancer. | 34500048 | Zhu Q, Meng Y, Li S, Xin J, Du M, Wang M, Cheng G | Gene | 2021 | PLCO |
| Genetic variants of CHEK1, PRIM2 and CDK6 in the mitotic phase-related pathway are associated with nonsmall cell lung cancer survival. | 34058013 | Mu R , Liu H , Luo S , Patz EF , Glass C , Su L , Du M , Christiani DC , Jin L , Wei Q | Int J Cancer | 2021 | PLCO |
| Assisted versus Manual Interpretation of Low-Dose CT Scans for Lung Cancer Screening: Impact on Lung-RADS Agreement. | 34559005 | Jacobs C, Schreuder A, van Riel SJ, Scholten ET, Wittenberg R, Wille MMW, de Hoop B, Sprengers R, Mets OM, Geurts B, Prokop M, Schaefer-Prokop C, van Ginneken B | Radiol Imaging Cancer | 2021 | NLST |
| Generalizability and Transportability of the National Lung Screening Trial Data: Extending Trial Results to Different Populations. | 34548326 | Inoue K, Hsu W, Arah OA, Prosper AE, Aberle DR, Bui AAT | Cancer Epidemiol Biomarkers Prev | 2021 | NLST |
| Scan-based competing death risk model for re-evaluating lung cancer computed tomography screening eligibility. | 34649976 | Schreuder A, Jacobs C, Lessmann N, Broeders MJM, Silva M, Išgum I, de Jong PA, van den Heuvel MM, Sverzellati N, Prokop M, Pastorino U, Schaefer-Prokop CM, van Ginneken B | Eur Respir J | 2021 | NLST |
| Doubly robust nonparametric instrumental variable estimators for survival outcomes. | 34676400 | Lee Y, Kennedy EH, Mitra N | Biostatistics | 2021 | PLCO |
| Gut Microbiome-Dependent Metabolic Pathways and Risk of Lethal Prostate Cancer: Prospective Analysis of a PLCO Cancer Screening Trial Cohort. | 34711629 | Reichard CA, Naelitz BD, Wang Z, Jia X, Li J, Stampfer MJ, Klein EA, Hazen SL, Sharifi N | Cancer Epidemiol Biomarkers Prev | 2021 | PLCO |
| Genetic Variants of CLEC4E and BIRC3 in Damage-Associated Molecular Patterns-Related Pathway Genes Predict Non-Small Cell Lung Cancer Survival. | 34692492 | Liu L, Liu H, Luo S, Patz EF, Glass C, Su L, Lin L, Christiani DC, Wei Q | Front Oncol | 2021 | PLCO |